The Effects of a Novel Nutritional Product on Nutrient Gaps and Gut Health in Active Adults
Not Applicable
Completed
- Conditions
- Gastrointestinal MicrobiomeNutrition, HealthyExercise
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: AG1 - Nutritional Supplement
- Registration Number
- NCT06521424
- Lead Sponsor
- Athletic Greens International
- Brief Summary
This study is a randomized, double-blind, placebo-controlled study of N=20 active men and women. This study to assess the effect of a novel dietary supplement on improving nutrient gaps and the gut microbiome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Provide voluntary signed and dated informed consent.
- Be in good health as determined by medical history and routine blood chemistries.
- > 1 year of resistance training experience (minimum of 2 days per week of resistance training session with free weights)
- Age between 18 and 40 yr (inclusive).
- Subject agrees to maintain existing dietary and physical activity patterns throughout the study period.
- Subject is willing and able to comply with the study protocol.
Exclusion Criteria
- History of unstable or new-onset cardiovascular/cardiorespiratory, liver, or renal conditions.
- History of diabetes or endocrine disorder.
- History of use of medications or dietary supplements known to confound the study or its endpoints.
- Alcohol consumption (more than 2 standard alcoholic drinks per day or more than 10 drinks per week) or drug abuse or dependence within the past 6 months.
- Current smokers or smoking within the past month.
- History of hyperparathyroidism or an untreated thyroid condition.
- History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).
- Prior gastrointestinal bypass surgery (Lapband), etc.
- Other known gastrointestinal or metabolic conditions that might impact nutrient absorption or metabolism, e.g., short bowel syndrome, Irritable bowel syndrome (IBS), diarrheal illnesses, history of colon resection, gastro paresis, Inborn-Errors-of-Metabolism (such as PKU).
- Chronic inflammatory condition (e.g., rheumatoid arthritis, Crohn's, ulcerative colitis, Lupus, HIV/AIDS, etc.).
- Previous medical diagnosis of asthma, gout, or fibromyalgia.
- Pregnant women, women trying to become pregnant, women less than 120 days postpartum or nursing women.
- Known sensitivity to any ingredient in the test formulations as listed in the product label.
- Currently participating in another research study with an investigational product or have been in another research study in the past 30 days.
- Any other conditions that, in the opinion of the medical staff, could confound the primary endpoints or place the subject at increased risk of harm if they were to participate.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Placebo Placebo Maltodextrin + Flavoring AG1 - Nutritional Supplement AG1 - Nutritional Supplement A foundational nutritional supplement consisting of vitamins, minerals, probiotics, prebiotics, and whole food ingredients
- Primary Outcome Measures
Name Time Method Nutrient Gaps 14 days Assess nutrient gaps by dietary record assessment utilizing The Automated Self-Administered 24-hour (ASA24®) Dietary Assessment Tool
Gut Microbiome 14 days Examine changes in the gut microbiome via fecal polar metabolomics measured by LC/MS
- Secondary Outcome Measures
Name Time Method Exploratory Digestive Measures 14 days A Digestive Quality of Life Questionnaire (DQLQ) will be utilized to assess the effect of the interventions on participant's digestive health. Scores range from 0 to 9 with a higher score indicating worse digestion associated with quality of life
Trial Locations
- Locations (1)
Hofstra University
🇺🇸Hempstead, New York, United States